metal-organic compounds
Diaquabis[1-hydroxy-2-(imidazol-3-ium-1-yl)-1,1′-ethylidenediphophonato-κ2O,O′]zinc(II)
aGerencia de Investigación y Aplicaciones, Centro Atómico Constituyentes, Comisión Nacional de Energía Atómica and, Escuela de Ciencia y Tecnología, Universidad Nacional General San Martín, Buenos Aires, Argentina
*Correspondence e-mail: freire@tandar.cnea.gov.ar
In the title complex, [Zn(C5H9NO7P2)2(H2O)2], the zinc atom is coordinated by two bidentate zoledronate [zoledronate = (2-(1-imidazole)-1-hydroxy-1,1′-ethylidenediphophonate)] ligands and two water molecules. The is 6. There is one half-molecule in the with the zinc atom located on a crystallographic inversion centre. The anion exists as a zwitterion with an overall charge of −1; the protonated nitrogen in the ring has a positive charge and the two phosphonates groups each have a single negative charge. There are two intramolecular O—H⋯O hydrogen bonds. The molecules are linked into a chain by intermolecular O—H⋯O hydrogen bonds. Adjacent chains are further linked by O—H⋯O hydrogen bonds involving the aqua ligands. An N—H⋯O interaction is also observed.
Related literature
For general background to bisphosphonates, see: Fleisch et al. (1968); Green et al. (1994); Fleisch (2000); Ross et al. (2004); Smith (2005); Ralston et al. (1989); Reid et al. (2005); Rauch & Glorieux (2005); Chesnut et al. (2004). For structures of transition metal (Ni, Co and Cu) complexes with the zoledronate anion, see: Cao et al. (2007, 2008). For metal complexes of other bisphosphonates (Etidronate and Pamidronate), see: Fernández et al. (2002); Li et al. (2008); Chen et al. (2008); Uchtman (1972). For a pentacoordinated zinc(II)–zoledronate complex, see: Freire & Vega (2009). For bond distances and angles in related structures, see: Coiro & Lamba (1989); Vega et al. (1996, 1998). For hydrogen-bond motifs, see: Bernstein et al. (1995).
Experimental
Crystal data
|
Refinement
|
|
Data collection: MSC/AFC Diffractometer Control Software (Molecular Structure Corporation, 1988); cell MSC/AFC Diffractometer Control Software; data reduction: MSC/AFC Diffractometer Control Software; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009).
Supporting information
https://doi.org/10.1107/S1600536809042858/bq2165sup1.cif
contains datablocks global, I. DOI:Structure factors: contains datablock I. DOI: https://doi.org/10.1107/S1600536809042858/bq2165Isup2.hkl
Zoledronic Acid was obtained from Gador S. A. laboratory. The present compound was obtained as subproduct in a Zoledronate recrystallization process.
The H atoms attached to O were found in a difference Fourier map, further idealized (O—H: 0.82 Å - 0.90 Å) and finally allowed to ride. Those attached to C and N were placed at calculated positions (C—H: 0.93 Å; C—H2: 0.97 Å; N—H2: 0.90 Å) and allowed to ride. Displacement factors were taken as U(H)isot = x.U(host), x: 1.2 (C—H); 1.5 (C—H2, N—H2, O—H).
The present work is part of a project directed to the preparation and characterization of coordination complexes obtained by the interaction among metals and organic molecules of relevant pharmacological interest like bisphosphonates. Bisphosphonate compounds, which are characterized by a P—C—P backbone, are analogues of naturally occurring pyrophosphates. As effective inhibitors of bone resoption, bisphosphonates are used in the treatment of various bone diseases and disorders of calcium metabolism, osteolityc tumor bone disease, non tumor induced hypercalcemia, Paget and osteoporosis (Fleisch, 2000; Ross et al., 2004; Smith, 2005; Ralston et al., 1989; Reid et al., 2005; Rauch et al., 2005 and Chesnut et al., 2004). The P—C—P base structure allows the bisphosphonates to bind to many metallic cations in particular divalent metal ions and as a result bisphosphonates may stick bone surfaces in vivo (Fleisch et al., 1968). Third generation bisphosphonates, like zoledronate, are characterized by having a cyclic side chain and belong to the nitrogen containing bisphosphonate group which are the most effective for medical treatment (Green et al., 1994). A large number of metal derivatives of other bisphosphonates, like Etidronate and Pamidronate are known where the bisphosphonate ligand displays a variety of coordination modes (Ferńandez, 2002; Li et al., 2008; Chen et al., 2008; Uchtman, 1972). In contrast, few metal derivatives of Zoledronic acid have been reported in CSD (Allen, 2002). The present compound is isostructural with two Co and Ni complexes (Cao et al., 2007).
So, we present herein the
of a Zinc-Zoledronate complex: monozinc dizoledronate dihydrate, (I), Zn.2(P2O7N2C5H9).2(H2O). We also synthesized a pentacoordinated complex of zinc (II), (Freire & Vega, 2009). The zoledronate anion exists as a zwitterion with an overall charge of -1; the protonated nitrogen in the ring has a positive charge and the two phosphonates groups each have a single negative charge.The ZnO6 coordination sphere (Fig. 1) is defined by O11, O21, O1W and and their (1 - x, 1 - y, 1 - z) counterparts generated by the inversion center on Zn1. Zn – O distances range from 2.041 (4) to 2.095 (4) Å, and octahedral angles between 86.2 (2) and 92.7 (2)°. The O11—Zn1—O21 zoledronate bite angle is 90.6 (2)° and the angle between two oxygen atoms of different zoledronates is O11A Zn1 O21 89.4 (2)°.
Each phosphonate has one protonated O atom, the extra electronic charge being shared by the remaining two non protonated O atoms. This fact define two distinct types of P—O bonds, as shown by the mean value in the following values of bond distances and angles: P—OH 1,572 (8), P - O 1.503 (5) Å, O—P—OH 109.45 (13), O—P—O 115.60 (14) °, this measure is in agreement with the results found for related molecules (Coiro et al., 1989; Vega et al., 1996; Vega et al., 1998). The phosphonates groups have slighty "staggered" conformations sight in the P1···P2 direction. When this staggering is observed the non bonded torsion angle O13—P1··· P2—O23 is 4.1 °. The imidazol ring is plane, maximum deviation from the L.S. mean plane is 0.0058 Å for C5. The ring and C2 are not coplanar, the angle determined between the plane of the ring and the bond N1—C2 is 3.2 ° and C2 is 0.0861 Å far from the plane of the ring. The torsion angle C1—C2—N1—C3 is of 104.1 (8) ° and it is possible to describe it like + Anti-Clinal (+ac).
In this compound there are two intramolecular hydrogen bonds O1W—H1WA···. O12 and the one generated by the center of symmetry (Fig. 1). These molecules form a chain by means of hydrogen bonds provided by O22—H22··· O23 (-x + 2,-y + 2,-z + 2) and O1—H1··· O23 (-x + 2,-y + 2,-z + 2) (Fig. 2). This chain joins other neighboring and similar chains by means of the hydrogen bonds O1W—H1WB··· O13 (x - 1, y, z), O12—H12··· O13 (-x + 2,-y + 2,-z + 1), and N2—H2··· O21 (-x + 2,-y + 1,-z + 2) (see Table 2), determining a three-dimensional net. In all this hydrogen-bonding network the presence of two homodromic rings (Bernstein et al., 1995) is observed: P2—O22—H22··· O23 (-x + 2,-y + 2,-z + 2) ···H1—O1—C1—P2 (R21(7)), P1—O12—H12··· O13—P1—O12—H12 (-x + 2,-y + 2,-z + 1)··· O13—P1 (R22(8)).
For general background to bisphosphonates, see: Fleisch et al. (1968); Green et al. (1994); Fleisch (2000); Ross et al. (2004); Smith (2005); Ralston et al. (1989); Reid et al. (2005); Rauch et al. (2005); Chesnut et al. (2004). For structures of transition metal (Ni, Co and Cu) complexes with the zoledronate anion, see: Cao et al. (2007, 2008). For metal complexes of other bisphosphonates (Etidronate and Pamidronate), see: Fernández et al. (2002); Li et al. (2008); Chen et al. (2008); Uchtman (1972). For a pentacoordinated zinc(II)–zoledronate complex, see: Freire & Vega (2009). For bond distances and angles in related structures, see: Coiro & Lamba (1989); Vega et al. (1996, 1998). For hydrogen-bond motifs, see: Bernstein et al. (1995).
Data collection: MSC/AFC Diffractometer Control Software (Molecular Structure Corporation, 1988); cell
MSC/AFC Diffractometer Control Software (Molecular Structure Corporation, 1988); data reduction: MSC/AFC Diffractometer Control Software (Molecular Structure Corporation, 1988); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).Fig. 1. : Molecular view of (I), showing the labeling scheme used. Hydrogen bonding is shown in dashed lines. | |
Fig. 2. : View of the intra chain H-bonds in (I). |
[Zn(C5H9N2O7P2)2(H2O)2] | Z = 1 |
Mr = 643.57 | F(000) = 328 |
Triclinic, P1 | Dx = 1.999 Mg m−3 |
Hall symbol: -P 1 | Mo Kα radiation, λ = 0.71073 Å |
a = 7.457 (1) Å | Cell parameters from 42 reflections |
b = 8.408 (2) Å | θ = 8–18° |
c = 9.843 (2) Å | µ = 1.54 mm−1 |
α = 105.06 (3)° | T = 293 K |
β = 112.23 (3)° | Prism, colorless |
γ = 97.05 (3)° | 0.18 × 0.11 × 0.05 mm |
V = 534.5 (2) Å3 |
Rigaku AFC6 Difractometer diffractometer | 1236 reflections with I > 2σ(I) |
Radiation source: fine-focus sealed tube | Rint = 0.050 |
Graphite monochromator | θmax = 25.5°, θmin = 2.4° |
ω/2θ scans | h = −9→9 |
Absorption correction: ψ scan (North et al., 1968) | k = −1→10 |
Tmin = 0.82, Tmax = 0.92 | l = −11→11 |
2426 measured reflections | 3 standard reflections every 150 reflections |
1990 independent reflections | intensity decay: <3% |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.052 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.152 | H-atom parameters constrained |
S = 1.04 | w = 1/[σ2(Fo2) + (0.0781P)2] where P = (Fo2 + 2Fc2)/3 |
1990 reflections | (Δ/σ)max < 0.001 |
160 parameters | Δρmax = 0.84 e Å−3 |
0 restraints | Δρmin = −0.94 e Å−3 |
[Zn(C5H9N2O7P2)2(H2O)2] | γ = 97.05 (3)° |
Mr = 643.57 | V = 534.5 (2) Å3 |
Triclinic, P1 | Z = 1 |
a = 7.457 (1) Å | Mo Kα radiation |
b = 8.408 (2) Å | µ = 1.54 mm−1 |
c = 9.843 (2) Å | T = 293 K |
α = 105.06 (3)° | 0.18 × 0.11 × 0.05 mm |
β = 112.23 (3)° |
Rigaku AFC6 Difractometer diffractometer | 1236 reflections with I > 2σ(I) |
Absorption correction: ψ scan (North et al., 1968) | Rint = 0.050 |
Tmin = 0.82, Tmax = 0.92 | 3 standard reflections every 150 reflections |
2426 measured reflections | intensity decay: <3% |
1990 independent reflections |
R[F2 > 2σ(F2)] = 0.052 | 0 restraints |
wR(F2) = 0.152 | H-atom parameters constrained |
S = 1.04 | Δρmax = 0.84 e Å−3 |
1990 reflections | Δρmin = −0.94 e Å−3 |
160 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
x | y | z | Uiso*/Ueq | ||
Zn1 | 0.5000 | 0.5000 | 0.5000 | 0.0266 (4) | |
P1 | 0.8731 (2) | 0.77240 (19) | 0.52403 (17) | 0.0172 (4) | |
P2 | 0.8422 (2) | 0.77671 (19) | 0.82873 (17) | 0.0186 (4) | |
O11 | 0.7109 (6) | 0.6106 (5) | 0.4453 (4) | 0.0211 (9) | |
O12 | 0.7749 (6) | 0.9268 (5) | 0.5228 (5) | 0.0242 (10) | |
H12 | 0.8403 | 1.0149 | 0.5264 | 0.036* | |
O13 | 1.0242 (6) | 0.7849 (5) | 0.4574 (5) | 0.0217 (9) | |
O21 | 0.6875 (6) | 0.6116 (5) | 0.7361 (5) | 0.0253 (10) | |
O22 | 0.7342 (6) | 0.9253 (5) | 0.8129 (5) | 0.0254 (10) | |
H22 | 0.8021 | 1.0216 | 0.8691 | 0.038* | |
O23 | 0.9654 (7) | 0.8002 (5) | 0.9969 (5) | 0.0249 (10) | |
O1 | 1.1578 (6) | 0.9545 (5) | 0.8097 (5) | 0.0261 (10) | |
H1 | 1.1019 | 1.0326 | 0.8140 | 0.039* | |
N1 | 1.2533 (8) | 0.6520 (6) | 0.8864 (6) | 0.0224 (11) | |
N2 | 1.3599 (9) | 0.5904 (8) | 1.0957 (7) | 0.0372 (15) | |
H2 | 1.3678 | 0.5388 | 1.1618 | 0.045* | |
C1 | 1.0088 (9) | 0.7937 (7) | 0.7310 (6) | 0.0183 (13) | |
C2 | 1.1243 (10) | 0.6535 (8) | 0.7302 (7) | 0.0271 (15) | |
H2A | 1.0288 | 0.5439 | 0.6719 | 0.032* | |
H2B | 1.2067 | 0.6680 | 0.6759 | 0.032* | |
C3 | 1.2149 (10) | 0.5438 (9) | 0.9533 (8) | 0.0315 (16) | |
H3 | 1.1052 | 0.4509 | 0.9084 | 0.038* | |
C5 | 1.4298 (10) | 0.7711 (8) | 0.9896 (8) | 0.0319 (16) | |
H5 | 1.4929 | 0.8611 | 0.9722 | 0.038* | |
C4 | 1.4926 (12) | 0.7303 (10) | 1.1212 (8) | 0.042 (2) | |
H4 | 1.6068 | 0.7885 | 1.2127 | 0.051* | |
O1W | 0.3851 (6) | 0.7142 (6) | 0.4904 (6) | 0.0349 (12) | |
H1WA | 0.4645 | 0.8074 | 0.5273 | 0.052* | |
H1WB | 0.2703 | 0.7245 | 0.4668 | 0.052* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Zn1 | 0.0278 (7) | 0.0212 (6) | 0.0247 (6) | 0.0057 (5) | 0.0079 (5) | 0.0030 (5) |
P1 | 0.0177 (8) | 0.0145 (8) | 0.0173 (8) | 0.0054 (6) | 0.0056 (7) | 0.0043 (6) |
P2 | 0.0194 (8) | 0.0157 (8) | 0.0150 (8) | 0.0029 (7) | 0.0048 (7) | 0.0008 (6) |
O11 | 0.020 (2) | 0.024 (2) | 0.014 (2) | 0.0010 (19) | 0.0059 (18) | 0.0015 (17) |
O12 | 0.026 (2) | 0.020 (2) | 0.035 (3) | 0.0118 (19) | 0.016 (2) | 0.015 (2) |
O13 | 0.022 (2) | 0.019 (2) | 0.025 (2) | 0.0082 (18) | 0.0116 (19) | 0.0051 (18) |
O21 | 0.029 (3) | 0.021 (2) | 0.017 (2) | 0.000 (2) | 0.006 (2) | 0.0027 (18) |
O22 | 0.028 (2) | 0.020 (2) | 0.024 (2) | 0.0100 (19) | 0.009 (2) | 0.0019 (19) |
O23 | 0.035 (3) | 0.021 (2) | 0.015 (2) | 0.005 (2) | 0.007 (2) | 0.0037 (18) |
O1 | 0.021 (2) | 0.018 (2) | 0.030 (2) | 0.0008 (19) | 0.007 (2) | 0.0003 (19) |
N1 | 0.023 (3) | 0.022 (3) | 0.021 (3) | 0.010 (2) | 0.006 (2) | 0.008 (2) |
N2 | 0.052 (4) | 0.039 (4) | 0.032 (3) | 0.018 (3) | 0.020 (3) | 0.025 (3) |
C1 | 0.023 (3) | 0.017 (3) | 0.017 (3) | 0.010 (3) | 0.007 (3) | 0.007 (2) |
C2 | 0.029 (4) | 0.023 (3) | 0.019 (3) | 0.010 (3) | 0.002 (3) | 0.004 (3) |
C3 | 0.027 (4) | 0.031 (4) | 0.044 (4) | 0.013 (3) | 0.016 (3) | 0.022 (3) |
C5 | 0.027 (4) | 0.026 (4) | 0.037 (4) | 0.008 (3) | 0.007 (3) | 0.012 (3) |
C4 | 0.048 (5) | 0.042 (5) | 0.025 (4) | 0.020 (4) | 0.000 (3) | 0.013 (3) |
O1W | 0.018 (2) | 0.022 (2) | 0.059 (3) | 0.007 (2) | 0.013 (2) | 0.011 (2) |
Zn1—O11i | 2.042 (4) | O1—H1 | 0.8201 |
Zn1—O11 | 2.042 (4) | N1—C3 | 1.317 (8) |
Zn1—O21 | 2.079 (4) | N1—C5 | 1.379 (8) |
Zn1—O21i | 2.079 (4) | N1—C2 | 1.478 (7) |
Zn1—O1Wi | 2.096 (4) | N2—C3 | 1.323 (9) |
Zn1—O1W | 2.096 (4) | N2—C4 | 1.341 (9) |
P1—O11 | 1.501 (4) | N2—H2 | 0.8600 |
P1—O13 | 1.509 (4) | C1—C2 | 1.543 (8) |
P1—O12 | 1.567 (4) | C2—H2A | 0.9700 |
P1—C1 | 1.847 (6) | C2—H2B | 0.9700 |
P2—O21 | 1.498 (4) | C3—H3 | 0.9300 |
P2—O23 | 1.502 (4) | C5—C4 | 1.352 (9) |
P2—O22 | 1.578 (4) | C5—H5 | 0.9300 |
P2—C1 | 1.850 (6) | C4—H4 | 0.9300 |
O12—H12 | 0.8200 | O1W—H1WA | 0.8200 |
O22—H22 | 0.8200 | O1W—H1WB | 0.8200 |
O1—C1 | 1.448 (7) | ||
O11i—Zn1—O11 | 180.0 | C1—O1—H1 | 109.4 |
O11i—Zn1—O21 | 89.35 (16) | C3—N1—C5 | 108.8 (6) |
O11—Zn1—O21 | 90.65 (16) | C3—N1—C2 | 126.2 (6) |
O11i—Zn1—O21i | 90.65 (16) | C5—N1—C2 | 125.0 (5) |
O11—Zn1—O21i | 89.35 (16) | C3—N2—C4 | 109.7 (6) |
O21—Zn1—O21i | 180.0 | C3—N2—H2 | 125.1 |
O11i—Zn1—O1Wi | 86.18 (18) | C4—N2—H2 | 125.1 |
O11—Zn1—O1Wi | 93.82 (18) | O1—C1—C2 | 106.5 (5) |
O21—Zn1—O1Wi | 87.37 (18) | O1—C1—P1 | 108.5 (4) |
O21i—Zn1—O1Wi | 92.63 (18) | C2—C1—P1 | 105.0 (4) |
O11i—Zn1—O1W | 93.82 (18) | O1—C1—P2 | 110.8 (4) |
O11—Zn1—O1W | 86.18 (18) | C2—C1—P2 | 112.6 (4) |
O21—Zn1—O1W | 92.63 (18) | P1—C1—P2 | 113.1 (3) |
O21i—Zn1—O1W | 87.37 (18) | N1—C2—C1 | 114.5 (5) |
O1Wi—Zn1—O1W | 180.000 (1) | N1—C2—H2A | 108.6 |
O11—P1—O13 | 115.5 (2) | C1—C2—H2A | 108.6 |
O11—P1—O12 | 108.9 (2) | N1—C2—H2B | 108.6 |
O13—P1—O12 | 109.9 (2) | C1—C2—H2B | 108.6 |
O11—P1—C1 | 108.2 (3) | H2A—C2—H2B | 107.6 |
O13—P1—C1 | 107.9 (3) | N1—C3—N2 | 108.0 (6) |
O12—P1—C1 | 106.0 (3) | N1—C3—H3 | 126.0 |
O21—P2—O23 | 115.7 (2) | N2—C3—H3 | 126.0 |
O21—P2—O22 | 108.0 (3) | C4—C5—N1 | 106.1 (6) |
O23—P2—O22 | 110.9 (2) | C4—C5—H5 | 127.0 |
O21—P2—C1 | 107.4 (3) | N1—C5—H5 | 127.0 |
O23—P2—C1 | 109.4 (3) | N2—C4—C5 | 107.4 (6) |
O22—P2—C1 | 104.9 (3) | N2—C4—H4 | 126.3 |
P1—O11—Zn1 | 134.2 (2) | C5—C4—H4 | 126.3 |
P1—O12—H12 | 117.6 | Zn1—O1W—H1WA | 118.1 |
P2—O21—Zn1 | 132.6 (3) | Zn1—O1W—H1WB | 130.4 |
P2—O22—H22 | 116.2 | H1WA—O1W—H1WB | 110.8 |
O13—P1—O11—Zn1 | 167.0 (3) | O12—P1—C1—P2 | 63.4 (3) |
O12—P1—O11—Zn1 | −68.8 (4) | O21—P2—C1—O1 | 177.3 (4) |
C1—P1—O11—Zn1 | 46.0 (4) | O23—P2—C1—O1 | −56.4 (4) |
O21—Zn1—O11—P1 | −30.0 (4) | O22—P2—C1—O1 | 62.6 (4) |
O21i—Zn1—O11—P1 | 150.0 (4) | O21—P2—C1—C2 | −63.6 (5) |
O1Wi—Zn1—O11—P1 | −117.4 (4) | O23—P2—C1—C2 | 62.7 (5) |
O1W—Zn1—O11—P1 | 62.6 (4) | O22—P2—C1—C2 | −178.3 (4) |
O23—P2—O21—Zn1 | −172.3 (3) | O21—P2—C1—P1 | 55.2 (4) |
O22—P2—O21—Zn1 | 62.8 (4) | O23—P2—C1—P1 | −178.5 (3) |
C1—P2—O21—Zn1 | −49.8 (4) | O22—P2—C1—P1 | −59.5 (3) |
O11i—Zn1—O21—P2 | −147.8 (4) | C3—N1—C2—C1 | 104.1 (7) |
O11—Zn1—O21—P2 | 32.2 (4) | C5—N1—C2—C1 | −72.1 (8) |
O1Wi—Zn1—O21—P2 | 126.0 (4) | O1—C1—C2—N1 | 62.2 (6) |
O1W—Zn1—O21—P2 | −54.0 (4) | P1—C1—C2—N1 | 177.1 (4) |
O11—P1—C1—O1 | −176.6 (3) | P2—C1—C2—N1 | −59.4 (6) |
O13—P1—C1—O1 | 57.8 (4) | C5—N1—C3—N2 | 0.4 (8) |
O12—P1—C1—O1 | −59.9 (4) | C2—N1—C3—N2 | −176.3 (6) |
O11—P1—C1—C2 | 69.9 (4) | C4—N2—C3—N1 | 0.3 (8) |
O13—P1—C1—C2 | −55.8 (4) | C3—N1—C5—C4 | −0.9 (8) |
O12—P1—C1—C2 | −173.4 (4) | C2—N1—C5—C4 | 175.8 (6) |
O11—P1—C1—P2 | −53.3 (4) | C3—N2—C4—C5 | −0.9 (9) |
O13—P1—C1—P2 | −178.9 (3) | N1—C5—C4—N2 | 1.1 (8) |
Symmetry code: (i) −x+1, −y+1, −z+1. |
D—H···A | D—H | H···A | D···A | D—H···A |
O22—H22···O23ii | 0.82 | 1.90 | 2.676 (6) | 159 |
O12—H12···O13iii | 0.82 | 1.79 | 2.607 (6) | 176 |
O1—H1···O23ii | 0.82 | 2.28 | 2.910 (6) | 134 |
O1W—H1WA···O12 | 0.82 | 2.43 | 3.078 (6) | 137 |
O1W—H1WB···O13iv | 0.82 | 1.94 | 2.745 (6) | 167 |
N2—H2···O21v | 0.86 | 1.90 | 2.740 (7) | 164 |
Symmetry codes: (ii) −x+2, −y+2, −z+2; (iii) −x+2, −y+2, −z+1; (iv) x−1, y, z; (v) −x+2, −y+1, −z+2. |
Experimental details
Crystal data | |
Chemical formula | [Zn(C5H9N2O7P2)2(H2O)2] |
Mr | 643.57 |
Crystal system, space group | Triclinic, P1 |
Temperature (K) | 293 |
a, b, c (Å) | 7.457 (1), 8.408 (2), 9.843 (2) |
α, β, γ (°) | 105.06 (3), 112.23 (3), 97.05 (3) |
V (Å3) | 534.5 (2) |
Z | 1 |
Radiation type | Mo Kα |
µ (mm−1) | 1.54 |
Crystal size (mm) | 0.18 × 0.11 × 0.05 |
Data collection | |
Diffractometer | Rigaku AFC6 Difractometer |
Absorption correction | ψ scan (North et al., 1968) |
Tmin, Tmax | 0.82, 0.92 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 2426, 1990, 1236 |
Rint | 0.050 |
(sin θ/λ)max (Å−1) | 0.606 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.052, 0.152, 1.04 |
No. of reflections | 1990 |
No. of parameters | 160 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.84, −0.94 |
Computer programs: MSC/AFC Diffractometer Control Software (Molecular Structure Corporation, 1988), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).
Zn1—O11 | 2.042 (4) | Zn1—O1W | 2.096 (4) |
Zn1—O21 | 2.079 (4) | ||
O11—Zn1—O21 | 90.65 (16) | O21—Zn1—O1W | 92.63 (18) |
O11—Zn1—O1W | 86.18 (18) |
D—H···A | D—H | H···A | D···A | D—H···A |
O22—H22···O23i | 0.82 | 1.90 | 2.676 (6) | 158.5 |
O12—H12···O13ii | 0.82 | 1.79 | 2.607 (6) | 176.0 |
O1—H1···O23i | 0.82 | 2.28 | 2.910 (6) | 133.7 |
O1W—H1WA···O12 | 0.82 | 2.43 | 3.078 (6) | 136.8 |
O1W—H1WB···O13iii | 0.82 | 1.94 | 2.745 (6) | 167.3 |
N2—H2···O21iv | 0.86 | 1.90 | 2.740 (7) | 163.8 |
Symmetry codes: (i) −x+2, −y+2, −z+2; (ii) −x+2, −y+2, −z+1; (iii) x−1, y, z; (iv) −x+2, −y+1, −z+2. |
Footnotes
‡Member of Consejo Nacional de Ciencia y Técnica, Conicet.
Acknowledgements
We acknowledge PICT 25409, the Spanish Research Council (CSIC) for providing us with a free-of-charge licence to use the CSD system (Allen, 2002) and Professor Judith Howard for the donation of a Rigaku AFC6S four-circle diffractometer. EF is a member of the research staff of Conicet. The authors are grateful to Laboratorios Gador for providing the zoledronic acid.
References
Allen, F. H. (2002). Acta Cryst. B58, 380–388. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555–1573. CrossRef CAS Web of Science Google Scholar
Cao, D.-K., Li, Y.-Z. & Zheng, L.-M. (2007). Inorg. Chem. 46, 7571–7578. Web of Science CSD CrossRef PubMed CAS Google Scholar
Cao, D.-K., Xie, X.-J., Li, Y.-Z. & Zheng, L.-M. (2008). Dalton Trans. pp. 5008–5015. Web of Science CSD CrossRef Google Scholar
Chen, H., Sun, Z., Dong, D., Meng, L., Zheng, X., Zhu, Y., Zha, Y. & Zhang, J. (2008). J. Coord. Chem. 61, 1316–1324. Web of Science CSD CrossRef CAS Google Scholar
Chesnut, C. H. III, Skag, A., Christiansen, C., Recker, R., Stakkestad, J. A., Hoiseth, A., Felsenberg, D., Huss, H., Gilbride, J., Schimmer, R. C. & Delmas, P. D. (2004). J. Bone Miner. Res. 19, 1241–1249. Web of Science CrossRef PubMed CAS Google Scholar
Coiro, V. M. & Lamba, D. (1989). Acta Cryst. C45, 446–448. CSD CrossRef CAS Web of Science IUCr Journals Google Scholar
Fernández, D., Vega, D. & Goeta, A. (2002). Acta Cryst. C58, m494–m497. Web of Science CSD CrossRef IUCr Journals Google Scholar
Fleisch, H. (2000). Bisphosphonates in Bone Disease. From the Laboratory to the Patient, 4th ed. New York: Academic Press. Google Scholar
Fleisch, H., Russell, R. G. G., Bisaz, S., Termine, J. D. & Posner, A. S. (1968). Calcif. Tissue Res. 2, 49–59. CrossRef CAS Web of Science Google Scholar
Freire, E. & Vega, D. R. (2009). Acta Cryst. E65, m1430–m1431. Web of Science CrossRef IUCr Journals Google Scholar
Green, J. R., Mueller, K. & Jaeggi, K. A. (1994). J. Bone Miner. Res. 9, 745–751. CrossRef CAS PubMed Web of Science Google Scholar
Li, G., Fan, Y., Zhang, T., Ge, T. & Hou, H. (2008). J. Coord. Chem. 61, 540–549. Web of Science CSD CrossRef CAS Google Scholar
Molecular Structure Corporation (1988). MSC/AFC Diffractometer Control Software. MSC, The Woodlands, Texas, USA. Google Scholar
North, A. C. T., Phillips, D. C. & Mathews, F. S. (1968). Acta Cryst. A24, 351–359. CrossRef IUCr Journals Web of Science Google Scholar
Ralston, S. H., Patel, U., Fraser, W. D., Gallacher, S. J., Dryburgh, F. J., Cowan, R. A. & Boyle, I. T. (1989). Lancet, 334, 1180–1182. CrossRef Google Scholar
Rauch, F. & Glorieux, F. H. (2005). Am. J. Med. Genet. C. Semin. Med. Genet. 139, 31–37. CrossRef Google Scholar
Reid, I. R., Miller, P., Lyles, K., Fraser, W., Brown, J. P., Saidi, Y., Mesenbrink, P., Su, G., Pak, J., Zelenakas, K., Luchi, M., Richardson, P. & Hosking, D. (2005). N. Engl. J. Med. 353, 898–908. Web of Science CrossRef PubMed CAS Google Scholar
Ross, J. R., Saunders, Y., Edmonds, P. M., Wonderling, D., Normand, C. & Broadley, K. (2004). Health Technol. Assess. 8, 1–176. CrossRef PubMed CAS Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Smith, M. R. (2005). Cancer Treat. Rev. 31 (Suppl 3), 19–25. Google Scholar
Spek, A. L. (2009). Acta Cryst. D65, 148–155. Web of Science CrossRef CAS IUCr Journals Google Scholar
Uchtman, V. A. (1972). J. Phys. Chem. 76, 1298–1304. CSD CrossRef CAS Web of Science Google Scholar
Vega, D., Baggio, R. & Garland, M. T. (1996). Acta Cryst. C52, 2198–2201. CSD CrossRef CAS Web of Science IUCr Journals Google Scholar
Vega, D., Baggio, R. & Piro, O. (1998). Acta Cryst. C54, 324–327. Web of Science CSD CrossRef CAS IUCr Journals Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
The present work is part of a project directed to the preparation and characterization of coordination complexes obtained by the interaction among metals and organic molecules of relevant pharmacological interest like bisphosphonates. Bisphosphonate compounds, which are characterized by a P—C—P backbone, are analogues of naturally occurring pyrophosphates. As effective inhibitors of bone resoption, bisphosphonates are used in the treatment of various bone diseases and disorders of calcium metabolism, osteolityc tumor bone disease, non tumor induced hypercalcemia, Paget and osteoporosis (Fleisch, 2000; Ross et al., 2004; Smith, 2005; Ralston et al., 1989; Reid et al., 2005; Rauch et al., 2005 and Chesnut et al., 2004). The P—C—P base structure allows the bisphosphonates to bind to many metallic cations in particular divalent metal ions and as a result bisphosphonates may stick bone surfaces in vivo (Fleisch et al., 1968). Third generation bisphosphonates, like zoledronate, are characterized by having a cyclic side chain and belong to the nitrogen containing bisphosphonate group which are the most effective for medical treatment (Green et al., 1994). A large number of metal derivatives of other bisphosphonates, like Etidronate and Pamidronate are known where the bisphosphonate ligand displays a variety of coordination modes (Ferńandez, 2002; Li et al., 2008; Chen et al., 2008; Uchtman, 1972). In contrast, few metal derivatives of Zoledronic acid have been reported in CSD (Allen, 2002). The present compound is isostructural with two Co and Ni complexes (Cao et al., 2007).
So, we present herein the crystal structure of a Zinc-Zoledronate complex: monozinc dizoledronate dihydrate, (I), Zn.2(P2O7N2C5H9).2(H2O). We also synthesized a pentacoordinated complex of zinc (II), (Freire & Vega, 2009). The zoledronate anion exists as a zwitterion with an overall charge of -1; the protonated nitrogen in the ring has a positive charge and the two phosphonates groups each have a single negative charge.
The ZnO6 coordination sphere (Fig. 1) is defined by O11, O21, O1W and and their (1 - x, 1 - y, 1 - z) counterparts generated by the inversion center on Zn1. Zn – O distances range from 2.041 (4) to 2.095 (4) Å, and octahedral angles between 86.2 (2) and 92.7 (2)°. The O11—Zn1—O21 zoledronate bite angle is 90.6 (2)° and the angle between two oxygen atoms of different zoledronates is O11A Zn1 O21 89.4 (2)°.
Each phosphonate has one protonated O atom, the extra electronic charge being shared by the remaining two non protonated O atoms. This fact define two distinct types of P—O bonds, as shown by the mean value in the following values of bond distances and angles: P—OH 1,572 (8), P - O 1.503 (5) Å, O—P—OH 109.45 (13), O—P—O 115.60 (14) °, this measure is in agreement with the results found for related molecules (Coiro et al., 1989; Vega et al., 1996; Vega et al., 1998). The phosphonates groups have slighty "staggered" conformations sight in the P1···P2 direction. When this staggering is observed the non bonded torsion angle O13—P1··· P2—O23 is 4.1 °. The imidazol ring is plane, maximum deviation from the L.S. mean plane is 0.0058 Å for C5. The ring and C2 are not coplanar, the angle determined between the plane of the ring and the bond N1—C2 is 3.2 ° and C2 is 0.0861 Å far from the plane of the ring. The torsion angle C1—C2—N1—C3 is of 104.1 (8) ° and it is possible to describe it like + Anti-Clinal (+ac).
In this compound there are two intramolecular hydrogen bonds O1W—H1WA···. O12 and the one generated by the center of symmetry (Fig. 1). These molecules form a chain by means of hydrogen bonds provided by O22—H22··· O23 (-x + 2,-y + 2,-z + 2) and O1—H1··· O23 (-x + 2,-y + 2,-z + 2) (Fig. 2). This chain joins other neighboring and similar chains by means of the hydrogen bonds O1W—H1WB··· O13 (x - 1, y, z), O12—H12··· O13 (-x + 2,-y + 2,-z + 1), and N2—H2··· O21 (-x + 2,-y + 1,-z + 2) (see Table 2), determining a three-dimensional net. In all this hydrogen-bonding network the presence of two homodromic rings (Bernstein et al., 1995) is observed: P2—O22—H22··· O23 (-x + 2,-y + 2,-z + 2) ···H1—O1—C1—P2 (R21(7)), P1—O12—H12··· O13—P1—O12—H12 (-x + 2,-y + 2,-z + 1)··· O13—P1 (R22(8)).